HCV Coinfection

Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)

deLIVER: Direct Acting Antiviral Effects on the Liver

Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients

Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens

Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B

Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure

Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03)

Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents

Testing and Linkage to Care for Injecting Drug Users in Kenya

Effect of Sofosbuvir-daclatasuvir on Angiogenesis

Integrating HIV and Hepatitis C Screening in an Urban Emergency Department

Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection

Ultrasound Method to Measure Fibrosis of the Liver in Children

Folinic Acid: Supplementation and Therapy

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir